Israel’s Serreno (reported here previously) reported over 96% accuracy in the trials of its Sentinel monitoring system for Acute Kidney Injury in three Israeli Intensive Care Units. The devices will now be manufactured by Israel’s Elcam Medical, which has also invested $1.5 million in Serreno.
https://www.calcalistech.com/ctech/articles/0,7340,L-3888772,00.html